• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Accenture plc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    2/6/25 4:16:54 PM ET
    $ACN
    Business Services
    Consumer Discretionary
    Get the next $ACN alert in real time by email
    acn-20250206
    0001467373false00014673732025-02-062025-02-06

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 8-K
    CURRENT REPORT
    Pursuant to Section 13 OR 15(d) of the
    Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): February 6, 2025

    AccentureLogo.jpg
    Accenture plc
    (Exact name of Registrant as specified in its charter)
    Ireland001-3444898-0627530
    (State or other jurisdiction
    of incorporation)
    (Commission
    File Number)
    (I.R.S. Employer
    Identification No.)
    1 Grand Canal Square
    Grand Canal Harbour
    Dublin 2, Ireland
    (Address of principal executive offices)
    Registrant’s telephone number, including area code: (353) (1) 646-2000
    Not Applicable
    (Former name or former address, if changed since last report)
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Class A ordinary shares, par value $0.0000225 per shareACNNew York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐





    Item 5.07 Submission of Matters to a Vote of Security Holders
    On February 6, 2025, Accenture plc (“Accenture”) held its 2025 annual general meeting of shareholders (the “Annual Meeting”). Accenture’s shareholders approved each of the following proposals considered at the Annual Meeting. The following chart sets forth the number and percentage of votes cast for and against, and the number of abstention votes and broker non-votes, with respect to each proposal voted upon by Accenture’s shareholders (proposal numbers correspond to the proposal numbers used in Accenture’s definitive proxy statement for the Annual Meeting, filed with the Securities and Exchange Commission on December 16, 2024):
    ProposalsForAgainstAbstainedBroker
    Non-Votes
    1.
    To appoint the following directors:
    Jaime Ardila
    424,496,622 92.30 %35,435,749 7.70 %908,067 52,321,086 
    Martin Brudermüller
    458,607,937 99.72 %1,266,538 0.28 %965,963 52,321,086 
    Alan Jope
    457,725,047 99.54 %2,134,079 0.46 %981,312 52,321,086 
    Nancy McKinstry
    343,225,648 74.62 %116,710,733 25.38 %904,057 52,321,086 
    Jennifer Nason
    439,572,948 95.58 %20,321,816 4.42 %945,674 52,321,086 
    Paula A. Price
    442,457,501 96.21 %17,440,579 3.79 %942,358 52,321,086 
    Venkata (Murthy) Renduchintala
    456,973,987 99.38 %2,849,069 0.62 %1,017,382 52,321,086 
    Arun Sarin
    423,626,038 92.11 %36,280,967 7.89 %933,433 52,321,086 
    Julie Sweet
    429,756,382 93.90 %27,910,081 6.10 %3,173,975 52,321,086 
    Tracey T. Travis
    456,811,694 99.34 %3,039,007 0.66 %989,737 52,321,086 
    Masahiko Uotani
    458,740,926 99.76 %1,097,572 0.24 %1,001,940 52,321,086 
    2.
    To approve, in a non-binding vote, the compensation of Accenture’s named executive officers
    413,337,606 90.14 %45,189,482 9.86 %2,313,350 52,321,086 
    3.
    To ratify, in a non-binding vote, the appointment of KPMG LLP (“KPMG”) as Accenture’s independent auditor and to authorize, in a binding vote, the Audit Committee of the Board of Directors (the “Board”) to determine KPMG’s remuneration
    476,706,662 93.19 %34,821,520 6.81 %1,633,342 — 
    4.To approve the creation of additional distributable reserves by way of a capital reduction510,943,821 99.78 %1,136,746 0.22 %1,080,957 — 
    5.
    To grant the Board the authority to issue shares under Irish law
    494,959,776 96.62 %17,334,302 3.38 %867,446 — 
    6.
    To grant the Board the authority to opt-out of pre-emption rights under Irish law
    471,601,832 92.14 %40,214,926 7.86 %1,344,766 — 
    7.
    To determine the price range at which Accenture can re-allot shares that it acquires as treasury shares under Irish law
    507,839,823 99.15 %4,377,404 0.85 %944,297 — 




    Signatures
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

    Date: February 6, 2025
    ACCENTURE PLC
    By:/s/ Joel Unruch
    Name:  Joel Unruch
    Title:General Counsel & Corporate Secretary



    Get the next $ACN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ACN

    DatePrice TargetRatingAnalyst
    3/17/2025$390.00Neutral → Outperform
    Robert W. Baird
    1/8/2025$425.00Peer Perform → Outperform
    Wolfe Research
    12/6/2024$370.00 → $420.00Neutral → Buy
    Goldman
    10/30/2024$375.00Outperform → Neutral
    Exane BNP Paribas
    9/30/2024$321.00 → $400.00Hold → Buy
    TD Cowen
    9/26/2024$329.00 → $395.00Neutral → Overweight
    Piper Sandler
    7/19/2024$400.00Neutral → Buy
    UBS
    6/26/2024$382.00 → $300.00Overweight → Equal-Weight
    Morgan Stanley
    More analyst ratings